Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke

NCT01769703 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01769703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01769703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
May 31, 2014
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

minor ischemic stroke, transient ischemic attack